Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_assertion description "[Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal non-MC lineage disease (SM-AHNMD), and mast cell leukemia (MCL) subgroups is a useful first step in establishing prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_assertion evidence source_evidence_literature NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_assertion SIO_000772 21442641 NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_assertion wasDerivedFrom befree-20140225 NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_assertion wasGeneratedBy ECO_0000203 NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP876095.RAFBeZELCljDtDzkA_8o9lzmZLxqXrZqoAWF1_NsYlqTM130_provenance.